AU8202198A - Pharmaceutical compositions comprising an angiostatic steroid combined with a hyaluronan - Google Patents
Pharmaceutical compositions comprising an angiostatic steroid combined with a hyaluronanInfo
- Publication number
- AU8202198A AU8202198A AU82021/98A AU8202198A AU8202198A AU 8202198 A AU8202198 A AU 8202198A AU 82021/98 A AU82021/98 A AU 82021/98A AU 8202198 A AU8202198 A AU 8202198A AU 8202198 A AU8202198 A AU 8202198A
- Authority
- AU
- Australia
- Prior art keywords
- hyaluronan
- pharmaceutical compositions
- angiostatic steroid
- combined
- steroid combined
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002208916A CA2208916A1 (en) | 1997-07-03 | 1997-07-03 | Promotion of wound healing utilizing steroids having reduced deterioroussystemic side effects typical of glucocorticoids, mineralocorticoids andsex steroids |
CA2208916 | 1997-07-03 | ||
PCT/CA1998/000649 WO1999001142A1 (en) | 1997-07-03 | 1998-07-03 | Pharmaceutical compositions comprising an angiostatic steroid combined with a hyaluronan |
Publications (1)
Publication Number | Publication Date |
---|---|
AU8202198A true AU8202198A (en) | 1999-01-25 |
Family
ID=4160953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU82021/98A Abandoned AU8202198A (en) | 1997-07-03 | 1998-07-03 | Pharmaceutical compositions comprising an angiostatic steroid combined with a hyaluronan |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU8202198A (en) |
CA (1) | CA2208916A1 (en) |
WO (1) | WO1999001142A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
US6908910B2 (en) | 1993-08-06 | 2005-06-21 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
US6995278B2 (en) | 2000-08-18 | 2006-02-07 | Entre Med, Inc. | Antiangiogenic agents |
US7135581B2 (en) | 2000-08-18 | 2006-11-14 | Entremed, Inc. | Antiangiogenic agents |
AU8838601A (en) * | 2000-11-27 | 2002-06-03 | Entremed Inc | Antiangiogenic agents |
US7498322B2 (en) | 2004-03-12 | 2009-03-03 | Entremed, Inc. | Antiangiogenic agents |
CA2646065C (en) | 2006-03-20 | 2014-01-14 | Entremed, Inc. | Disease modifying anti-arthritic activity of 2-methoxyestradiol |
FR2918892B1 (en) * | 2007-07-16 | 2010-02-12 | Fabre Pierre Dermo Cosmetique | ANTI-INFLAMMATORY DERMATOLOGICAL COMPOSITION COMPRISING CORTICIDES AND HYALURONATE FRAGMENTS, AND USES THEREOF |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4946870A (en) * | 1986-06-06 | 1990-08-07 | Union Carbide Chemicals And Plastics Company Inc. | Delivery systems for pharmaceutical or therapeutic actives |
WO1990015816A1 (en) * | 1989-06-16 | 1990-12-27 | The Upjohn Company | Suramin type compounds and angiostatic steroids to inhibit angiogenesis |
-
1997
- 1997-07-03 CA CA002208916A patent/CA2208916A1/en not_active Abandoned
-
1998
- 1998-07-03 WO PCT/CA1998/000649 patent/WO1999001142A1/en active Application Filing
- 1998-07-03 AU AU82021/98A patent/AU8202198A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2208916A1 (en) | 1999-01-03 |
WO1999001142A1 (en) | 1999-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4762797A (en) | Pharmaceutical compositions | |
AU6216296A (en) | Pharmaceutical compositions | |
AU6513298A (en) | Therapeutic compositions | |
AU6740298A (en) | Pharmaceutical composition | |
AU2967597A (en) | Pharmaceutical compositions | |
AU3192700A (en) | Medicinal compositions | |
AU3556400A (en) | Pharmaceutical compositions | |
AU8107998A (en) | Pharmaceutical compositions | |
AU3777897A (en) | Pharmaceutical compositions | |
AU4328800A (en) | Pharmaceutical formulation | |
AU1306997A (en) | Pharmaceutical compositions with vitamin d analogues | |
AU8747998A (en) | Anti-inflammatory agent | |
AU8202198A (en) | Pharmaceutical compositions comprising an angiostatic steroid combined with a hyaluronan | |
AU5274096A (en) | Pharmaceutical compositions | |
AU9343098A (en) | Pharmaceutical composition | |
AU5326298A (en) | Pharmaceutical compositions containing N-sulphonylindoline derivatives | |
AU3460897A (en) | Medicinal compositions | |
AU6460200A (en) | Pharmaceutical compositions | |
AU4636396A (en) | Antiglucocorticoid medicament | |
AUPP332898A0 (en) | Pharmaceutical composition | |
AU4326197A (en) | Pharmaceutical compositions | |
AU6460300A (en) | Pharmaceutical compositions | |
AU3839900A (en) | Pharmaceutical formulation | |
AU5296799A (en) | Pharmaceutical compositions against autoimmune diseases | |
AUPN862596A0 (en) | Pharmaceutical compositions |